deaths (OS)

mML - L1 - all population metastatic/adv melanoma (mML) mML - 1st line (L1) mML - L1 - all population

versus ipilimumab alone
nivolumab plus ipilimumab vs. ipilimumab alone 2 statistically conclusive-38%
versus nivolumab alone
nivolumab plus ipilimumab vs. nivolumab alone 1 certainty unassessable-32%